XPO heads into the open after reporting Q1 2026 results this morning — and the numbers came in clean. Adjusted EPS of $1.01 beat the $0.88 consensus by 15%. Revenue of $2.096B cleared the $2.038B estimate. The print arrives into a week where the stock slipped 2% to $216.71, and where short sellers have been quietly adding exposure in the background. That tension — a solid beat against a softening share price and a short position that has been growing — is the story worth unpacking.
Short interest has crept up meaningfully over the past week. It rose 7.6% in seven days to reach 5.4% of the float — roughly 6.34 million shares — the highest level in six weeks. That said, the lending market is anything but panicked. Cost to borrow eased to 0.46% after dipping below 0.70% throughout April, and availability in the borrow pool remains wide open relative to the short position. Nothing in the lending market suggests acute squeeze pressure; this looks more like measured repositioning ahead of earnings than a conviction short. The ORTEX short score at 43.9 is broadly neutral and has barely moved over the past fortnight, consistent with that read.
Options positioning has been consistently defensive, but not at an extreme. The put/call ratio of 1.41 is essentially in line with its 20-day average of 1.42 — a z-score of -0.73 — meaning options traders came into today's print with roughly the same lean toward downside protection as they have held all month. The 52-week range for the PCR runs from 0.52 to 4.02, so the current level is nowhere near peak defensiveness. The Street went into Q1 numbers with hedges on, but not heavy ones.
Analyst activity over the past month has tilted clearly positive. Jefferies raised its target to $275 (from $250) on April 22, keeping a Buy. Stifel lifted to $232 from $206 on April 16, also Buy. Wells Fargo moved to $225 from $205 on April 7, Overweight. The bear voices are fewer: Citigroup nudged its Neutral target only marginally to $207, and Evercore trimmed to $198. The mean target of $207.78 sits modestly below the current price of $216.71 — notable because it implies the Street's consensus is not yet reflecting the run the stock has made. Forward EPS momentum ranks in the 82nd percentile on a 90-day basis, and the 87th percentile on a 12-month forward basis, suggesting estimate revisions have been running hard in the right direction. Valuation has drifted upward too: the PE of ~44x has expanded roughly 3.4 turns over 30 days. At 19.8x EV/EBITDA — down half a turn on the week — the market is paying a premium for the LTL carrier story, and today's beat does at least provide some fundamental support for that premium.
Peer performance this week adds texture. SAIA fell 2.2% and ODFL dropped 4.8% on the week — both pure-play LTL names that faced more pressure than XPO's 2% slide. ARCB, by contrast, rallied 7.3%. The divergence within the group underscores that the LTL sector is trading on individual execution rather than a clean macro tailwind, which makes quarterly prints like today's especially consequential for separating the outperformers from the laggards.
The historical pattern offers a useful reference point. At the Q4 2025 print in February, XPO jumped 11.4% on day one and held a further 5.2% over the following five days — the last two comparable prints both showed double-digit one-day moves and followed-through over the week. Whether today's result, which beat on both lines, produces a similar reaction will hinge on how the market reads management's forward commentary on LTL volumes, pricing, and the drag from any macro uncertainty. The key watch now is whether the intraday trading on the beat resolves the short-interest rebuild — or encourages more of it.
See the live data behind this article on ORTEX.
Open XPO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
